Pub Date : 2023-10-26DOI: 10.31925/farmacia.2023.5.13
Magdalena Mititelu
With a cross-sectional observational study based on a questionnaire, the adherence of the Romanian population to a balanced diet and a healthy lifestyle was evaluated, as well as nutritional imbalances in correlation with the health status of the respondents. A total number of 2352 valid answers was registered from 66.7% female respondents and 33.3% male respondents. Regarding the respondents' adherence to a healthy diet correlated with a balanced lifestyle, it was found that only 4.3% of the respondents adopt a balanced diet. Most of the respondents who belong to the group of those with
{"title":"EVALUATION OF NUTRITIONAL STATUS AND ADHERENCE TO A HEALTHY DIET AMONG THE ROMANIAN POPULATION","authors":"Magdalena Mititelu","doi":"10.31925/farmacia.2023.5.13","DOIUrl":"https://doi.org/10.31925/farmacia.2023.5.13","url":null,"abstract":"With a cross-sectional observational study based on a questionnaire, the adherence of the Romanian population to a balanced diet and a healthy lifestyle was evaluated, as well as nutritional imbalances in correlation with the health status of the respondents. A total number of 2352 valid answers was registered from 66.7% female respondents and 33.3% male respondents. Regarding the respondents' adherence to a healthy diet correlated with a balanced lifestyle, it was found that only 4.3% of the respondents adopt a balanced diet. Most of the respondents who belong to the group of those with","PeriodicalId":12344,"journal":{"name":"FARMACIA","volume":"69 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139313389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-26DOI: 10.31925/farmacia.2023.5.8
Ajaz AHMAD
The present study focuses on optimizing the extraction process of sinapic acid from Fragaria ananassa using ultrasonic-assisted extraction (UAE). The extraction process study variables were: temperature in the range of 20 to 60°C, extraction time between 20 and 90 minutes and the solid-to-liquid ratio ranging from 10 to 30 mL/g. Response surface analysis determined that the most favourable conditions for sinapic acid extraction were at a temperature of 60°C, extraction time of 55 minutes and at a liquid-to-solid ratio of 30 mL/g. Under these conditions, the extraction yield of sinapic acid was measured at 23.56 mg/g. The experimental results closely aligned with the predicted values, affirming the reliability of the proposed model. Furthermore, UAE proved to be a highly effective method, exhibiting significantly reduced extraction time and producing higher levels of sinapic acid compared to traditional extraction techniques. HPLC analysis confirmed the presence of substantial amounts of sinapic acid in Fragaria ananassa . In conclusion, the optimized UAE method, in conjunction with HPLC-UV analysis, presents a valuable approach for the efficient extraction and estimation of sinapic acid from Fragaria ananassa . These results have the potential to greatly benefit industrial applications that need for extremely high extraction yields of these organic molecules.
{"title":"A BOX-BEHNKEN DESIGN FOR OPTIMIZATION OF ULTRASOUND-ASSISTED EXTRACTION OF SINAPIC ACID FROM FRAGARIA ANANASSA","authors":"Ajaz AHMAD","doi":"10.31925/farmacia.2023.5.8","DOIUrl":"https://doi.org/10.31925/farmacia.2023.5.8","url":null,"abstract":"The present study focuses on optimizing the extraction process of sinapic acid from Fragaria ananassa using ultrasonic-assisted extraction (UAE). The extraction process study variables were: temperature in the range of 20 to 60°C, extraction time between 20 and 90 minutes and the solid-to-liquid ratio ranging from 10 to 30 mL/g. Response surface analysis determined that the most favourable conditions for sinapic acid extraction were at a temperature of 60°C, extraction time of 55 minutes and at a liquid-to-solid ratio of 30 mL/g. Under these conditions, the extraction yield of sinapic acid was measured at 23.56 mg/g. The experimental results closely aligned with the predicted values, affirming the reliability of the proposed model. Furthermore, UAE proved to be a highly effective method, exhibiting significantly reduced extraction time and producing higher levels of sinapic acid compared to traditional extraction techniques. HPLC analysis confirmed the presence of substantial amounts of sinapic acid in Fragaria ananassa . In conclusion, the optimized UAE method, in conjunction with HPLC-UV analysis, presents a valuable approach for the efficient extraction and estimation of sinapic acid from Fragaria ananassa . These results have the potential to greatly benefit industrial applications that need for extremely high extraction yields of these organic molecules.","PeriodicalId":12344,"journal":{"name":"FARMACIA","volume":"198 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139313482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-26DOI: 10.31925/farmacia.2023.5.11
Florica BĂGESCU-DRUGĂ POP
This prospective, randomised study aimed to assess the efficacy of ketamine/propofol (K/P) compared to the commonly used fentanyl/midazolam (F/M) combination in providing analgesia for patients with severe pelvic and spinal trauma. The study, conducted over 30 months on 154 patients, found that the K/P group experienced significantly lower perceived pain levels, as measured on the numerical pain scale, when compared to the F/M group (p < 0.0001). Additionally, patients in the K/P group achieved adequate sedation with an average Ramsay scale score of 3.1, while the F/M group had a more profound sedation with a score of 5.5 (p < 0.0001). Furthermore, the study demonstrated that analgesia with K/P significantly improved the physiological severity score (PSS) (p < 0.0001) and resulted in a notably lower incidence of oxygen desaturation, with only one patient experiencing this in the K/P group compared to 16 patients in the F/M group (p = 0.0003). These findings suggest that co-administration of low-dose ketamine and propofol provides safe and effective sedation and analgesia, both in the emergency department and pre-hospital settings. The study highlights the importance of adequate pain management in severe trauma cases and emphasizes the potential advantages of using the K/P combination over F/M, particularly due to the reduced risk of oxygen desaturation and the more moderate level of sedation achieved with K/P. These results underscore the potential clinical utility of this approach in improving the overall care and outcomes of patients with severe pelvic and spinal trauma
{"title":"THE IMPORTANCE OF ANALGO-SEDATION IN THE PATIENT WITH SERIOUS PELVIC AND SPINE TRAUMA DURING TRANSPORT","authors":"Florica BĂGESCU-DRUGĂ POP","doi":"10.31925/farmacia.2023.5.11","DOIUrl":"https://doi.org/10.31925/farmacia.2023.5.11","url":null,"abstract":"This prospective, randomised study aimed to assess the efficacy of ketamine/propofol (K/P) compared to the commonly used fentanyl/midazolam (F/M) combination in providing analgesia for patients with severe pelvic and spinal trauma. The study, conducted over 30 months on 154 patients, found that the K/P group experienced significantly lower perceived pain levels, as measured on the numerical pain scale, when compared to the F/M group (p < 0.0001). Additionally, patients in the K/P group achieved adequate sedation with an average Ramsay scale score of 3.1, while the F/M group had a more profound sedation with a score of 5.5 (p < 0.0001). Furthermore, the study demonstrated that analgesia with K/P significantly improved the physiological severity score (PSS) (p < 0.0001) and resulted in a notably lower incidence of oxygen desaturation, with only one patient experiencing this in the K/P group compared to 16 patients in the F/M group (p = 0.0003). These findings suggest that co-administration of low-dose ketamine and propofol provides safe and effective sedation and analgesia, both in the emergency department and pre-hospital settings. The study highlights the importance of adequate pain management in severe trauma cases and emphasizes the potential advantages of using the K/P combination over F/M, particularly due to the reduced risk of oxygen desaturation and the more moderate level of sedation achieved with K/P. These results underscore the potential clinical utility of this approach in improving the overall care and outcomes of patients with severe pelvic and spinal trauma","PeriodicalId":12344,"journal":{"name":"FARMACIA","volume":"60 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139313264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-26DOI: 10.31925/farmacia.2023.5.20
Esam Y QNAIS
This study aimed to investigate the antinociceptive properties of galangin using various nociception models. Galangin's effects were assessed across different doses (50, 100, 150, and 200 µg/kg bw) in mice through multiple pain tests. The results were compared to those of mice treated with acetylsalicylic acid or morphine, with or without naloxone. In addition to standard pain models, capsaicin-and glutamate-induced tests were employed to explore the involvement of the vanilloid and glutamatergic systems in galangin's pain-relief mechanisms. It was found that galangin exhibited a significant, dose-dependent reduction in pain behaviour during the acetic acid-induced writhing test, with a 72.2% inhibition observed at a 200 µg/kg bw dose. In the hot plate test, it increased latency period, with a 72.0% increase at the same dose. Galangin also significantly inhibited both neurogenic and inflammatory phases in the formalin-induced paw-licking test. These effects were reversed by naloxone treatment, indicating opioid system involvement. Galangin further showed inhibitory effects on neurogenic nociception induced by capsaicin and glutamate. Enzyme-linked immunosorbent assay (ELISA) revealed that galangin, at doses of 100 and 200 µg/kg bw, significantly reduced pro-inflammatory cytokine levels (IL-1β, TNF-α, IFN-γ, and NO) in mouse serum. The study concluded that galangin possesses antinociceptive activity mediated through central and peripheral pathways, modulating vanilloid receptors, opioid receptors
{"title":"THE ANALGESIC PROPERTIES OF THE FLAVONOID GALANGIN IN EXPERIMENTAL ANIMAL MODELS OF NOCICEPTION","authors":"Esam Y QNAIS","doi":"10.31925/farmacia.2023.5.20","DOIUrl":"https://doi.org/10.31925/farmacia.2023.5.20","url":null,"abstract":"This study aimed to investigate the antinociceptive properties of galangin using various nociception models. Galangin's effects were assessed across different doses (50, 100, 150, and 200 µg/kg bw) in mice through multiple pain tests. The results were compared to those of mice treated with acetylsalicylic acid or morphine, with or without naloxone. In addition to standard pain models, capsaicin-and glutamate-induced tests were employed to explore the involvement of the vanilloid and glutamatergic systems in galangin's pain-relief mechanisms. It was found that galangin exhibited a significant, dose-dependent reduction in pain behaviour during the acetic acid-induced writhing test, with a 72.2% inhibition observed at a 200 µg/kg bw dose. In the hot plate test, it increased latency period, with a 72.0% increase at the same dose. Galangin also significantly inhibited both neurogenic and inflammatory phases in the formalin-induced paw-licking test. These effects were reversed by naloxone treatment, indicating opioid system involvement. Galangin further showed inhibitory effects on neurogenic nociception induced by capsaicin and glutamate. Enzyme-linked immunosorbent assay (ELISA) revealed that galangin, at doses of 100 and 200 µg/kg bw, significantly reduced pro-inflammatory cytokine levels (IL-1β, TNF-α, IFN-γ, and NO) in mouse serum. The study concluded that galangin possesses antinociceptive activity mediated through central and peripheral pathways, modulating vanilloid receptors, opioid receptors","PeriodicalId":12344,"journal":{"name":"FARMACIA","volume":"67 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139313640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-26DOI: 10.31925/farmacia.2023.5.10
E. F. Apriani
Clindamycin HCl is an antibiotic with limited bioavailability ranging from 0.7% to 12.9% of the applied dose. The ethosomal delivery system can increase the bioavailability of clindamycin HCl. However, in the manufacturing process, the speed and time of stirring are essential factors that affect the characterization of the resulting ethosomes. This study aims to optimize the clindamycin HCl ethosomal formula by varying the stirring speed (7,600 and 15,000 rpm) and stirring time (15 and 30 minutes) using ultra-turrax with a 2 2 factorial design method. The ethosomal formula was characterized including entrapment efficiency, particle size, polydispersity index and potential zeta. The optimum formula was tested for stability according to the ICH Q1A (R2) standard. The optimum formula was obtained at a stirring speed of 7,600 rpm and a stirring time of 15 minutes with an entrapment efficiency percentage of 72.38 ± 0.36%, a particle size of 270.80 ± 8.69 nm, a polydispersity index of 0.111 ± 0.032 and a potential zeta of -31.21 ± 0.82 mV. The results of the ICH Q1A (R2) stability test showed that the release model of the active substance followed order 0, the activation energy was 4.232 cal/mol, the kinetic constant was 9.897/day with a shelf life of 7.293 days at 25 ± 2°C/60 ± 5% RH and 8.247 days at
{"title":"EFFECT OF STIRRING SPEED AND STIRRING TIME ON CHARACTERIZATION OF CLINDAMYCIN HCL ETHOSOMAL AND ICH Q1A (R2) STABILITY TEST","authors":"E. F. Apriani","doi":"10.31925/farmacia.2023.5.10","DOIUrl":"https://doi.org/10.31925/farmacia.2023.5.10","url":null,"abstract":"Clindamycin HCl is an antibiotic with limited bioavailability ranging from 0.7% to 12.9% of the applied dose. The ethosomal delivery system can increase the bioavailability of clindamycin HCl. However, in the manufacturing process, the speed and time of stirring are essential factors that affect the characterization of the resulting ethosomes. This study aims to optimize the clindamycin HCl ethosomal formula by varying the stirring speed (7,600 and 15,000 rpm) and stirring time (15 and 30 minutes) using ultra-turrax with a 2 2 factorial design method. The ethosomal formula was characterized including entrapment efficiency, particle size, polydispersity index and potential zeta. The optimum formula was tested for stability according to the ICH Q1A (R2) standard. The optimum formula was obtained at a stirring speed of 7,600 rpm and a stirring time of 15 minutes with an entrapment efficiency percentage of 72.38 ± 0.36%, a particle size of 270.80 ± 8.69 nm, a polydispersity index of 0.111 ± 0.032 and a potential zeta of -31.21 ± 0.82 mV. The results of the ICH Q1A (R2) stability test showed that the release model of the active substance followed order 0, the activation energy was 4.232 cal/mol, the kinetic constant was 9.897/day with a shelf life of 7.293 days at 25 ± 2°C/60 ± 5% RH and 8.247 days at","PeriodicalId":12344,"journal":{"name":"FARMACIA","volume":"1 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139313734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-26DOI: 10.31925/farmacia.2023.5.3
LAURENȚIU TUDOR
This study comprehensively explores the integration of essential oils (EOs) into dairy livestock nutrition and milk production, focusing on optimising various facets of dairy farming. Food safety and biosecurity are paramount when introducing EOs into dairy farming practices. Rigorous safety assessments, including toxicity, allergenicity and potential adverse effects on animal health, are essential for the welfare of both livestock and consumers. Additionally, managing EO residues is challenging due to their potential impact on dairy product composition. Moreover, the variable effects of EOs on dairy animals` performance add complexity. While EOs show potential for inhibiting oxidative reactions and microbial spoilage, their influence on nutrient utilisation, ruminal fermentation and milk performance varies. Extensive research is required to optimise EO dosage and formulation for consistent performance benefits. Sustainability is a critical concern, requiring the alignment of EO utilisation with sustainable agricultural practices to address environmental and resource constraints. Lastly, consumer perception and acceptance are vital, necessitating transparent communication and an understanding of consumer preferences to maintain trust in dairy products. Addressing these challenges enables the dairy industry to harness the full potential of EOs, ensuring ongoing safety, quality and sustainability in dairy product production. This study provides practical insights and outlines future research directions to advance dairy production, quality and safety. Rezumat
本研究全面探讨了将精油（EO）融入奶畜营养和牛奶生产的问题，重点是优化奶牛养殖的各个方面。在奶牛养殖实践中引入 EO 时，食品安全和生物安全至关重要。严格的安全评估，包括毒性、过敏性和对动物健康的潜在不利影响，对牲畜和消费者的福利都至关重要。此外，由于环氧乙烷对乳制品成分的潜在影响，管理环氧乙烷残留物也具有挑战性。此外，环氧乙烷对乳制品动物性能的不同影响也增加了复杂性。虽然环氧乙烷具有抑制氧化反应和微生物腐败的潜力，但其对养分利用、瘤胃发酵和牛奶性能的影响却各不相同。需要进行广泛研究，优化环氧乙烷的用量和配方，以获得一致的性能优势。可持续性是一个关键问题，需要将环氧乙烷的利用与可持续农业实践相结合，以解决环境和资源限制问题。最后，消费者的认知和接受程度至关重要，这就需要透明的沟通和对消费者偏好的了解，以保持对乳制品的信任。应对这些挑战可使乳制品行业充分利用环氧乙烷的潜力，确保乳制品生产的持续安全、质量和可持续性。本研究提供了实用的见解，并概述了未来的研究方向，以促进乳制品的生产、质量和安全。网站地图
{"title":"OPTIMIZING MILK PRODUCTION, QUALITY AND SAFETY THROUGH ESSENTIAL OIL APPLICATIONS","authors":"LAURENȚIU TUDOR","doi":"10.31925/farmacia.2023.5.3","DOIUrl":"https://doi.org/10.31925/farmacia.2023.5.3","url":null,"abstract":"This study comprehensively explores the integration of essential oils (EOs) into dairy livestock nutrition and milk production, focusing on optimising various facets of dairy farming. Food safety and biosecurity are paramount when introducing EOs into dairy farming practices. Rigorous safety assessments, including toxicity, allergenicity and potential adverse effects on animal health, are essential for the welfare of both livestock and consumers. Additionally, managing EO residues is challenging due to their potential impact on dairy product composition. Moreover, the variable effects of EOs on dairy animals` performance add complexity. While EOs show potential for inhibiting oxidative reactions and microbial spoilage, their influence on nutrient utilisation, ruminal fermentation and milk performance varies. Extensive research is required to optimise EO dosage and formulation for consistent performance benefits. Sustainability is a critical concern, requiring the alignment of EO utilisation with sustainable agricultural practices to address environmental and resource constraints. Lastly, consumer perception and acceptance are vital, necessitating transparent communication and an understanding of consumer preferences to maintain trust in dairy products. Addressing these challenges enables the dairy industry to harness the full potential of EOs, ensuring ongoing safety, quality and sustainability in dairy product production. This study provides practical insights and outlines future research directions to advance dairy production, quality and safety. Rezumat","PeriodicalId":12344,"journal":{"name":"FARMACIA","volume":"46 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139313761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-26DOI: 10.31925/farmacia.2023.5.18
Manar Adnan Tamer
This research aimed to create and refine intranasal mucoadhesive amisulpride-loaded nanostructured lipid carriers (AMS-MNLCs) to increase efficacy and safety by increasing nasal-mucosal adhesion and facilitating direct brain targetability. Using HPMC K4M, Carbopol 934, and Hyaluronic acid (HA), AMS-MNLCs were made by applying modified melt-emulsification and ultra-sonication procedures. The results of the pH, osmolarity, and mucoadhesive tests on the optimized formulation were 6.3 ± 0.02, 304.53 ± 2.15, and 26.07 ± 0.37, respectively. Rheological investigation, in-vitro release and ex-vivo permeation study of the optimized formulation revealed a shear-thinning behaviour, significantly higher release, and the flux of the drug from the formula was 975.2 ± 12.45. Based on the pharmacokinetic analyses in rats, intranasal AMS-MNLCs were reported to have a brain C max about 14 times higher than intravenous AMS-solution. In addition, two weeks of intranasal administration of formulation did not affect haematological parameters in the in vivo research. The histopathological investigation showed that there was no disruption of the naso-mucosal membrane structure. Therefore, the created and optimized intranasal MNLCs showed a promised venue for the efficient and secure delivery of AMS as an antiemetic drug for the prevention and treatment of preoperative nausea and vomiting (PONV).
{"title":"THE DEVELOPMENT OF A BRAIN TARGETED MUCOADHESIVE AMISULPRIDE LOADED NANOSTRUCTURED LIPID CARRIER","authors":"Manar Adnan Tamer","doi":"10.31925/farmacia.2023.5.18","DOIUrl":"https://doi.org/10.31925/farmacia.2023.5.18","url":null,"abstract":"This research aimed to create and refine intranasal mucoadhesive amisulpride-loaded nanostructured lipid carriers (AMS-MNLCs) to increase efficacy and safety by increasing nasal-mucosal adhesion and facilitating direct brain targetability. Using HPMC K4M, Carbopol 934, and Hyaluronic acid (HA), AMS-MNLCs were made by applying modified melt-emulsification and ultra-sonication procedures. The results of the pH, osmolarity, and mucoadhesive tests on the optimized formulation were 6.3 ± 0.02, 304.53 ± 2.15, and 26.07 ± 0.37, respectively. Rheological investigation, in-vitro release and ex-vivo permeation study of the optimized formulation revealed a shear-thinning behaviour, significantly higher release, and the flux of the drug from the formula was 975.2 ± 12.45. Based on the pharmacokinetic analyses in rats, intranasal AMS-MNLCs were reported to have a brain C max about 14 times higher than intravenous AMS-solution. In addition, two weeks of intranasal administration of formulation did not affect haematological parameters in the in vivo research. The histopathological investigation showed that there was no disruption of the naso-mucosal membrane structure. Therefore, the created and optimized intranasal MNLCs showed a promised venue for the efficient and secure delivery of AMS as an antiemetic drug for the prevention and treatment of preoperative nausea and vomiting (PONV).","PeriodicalId":12344,"journal":{"name":"FARMACIA","volume":"11 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139313175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-26DOI: 10.31925/farmacia.2023.5.22
JINZHI TAN
To investigate the risk factors for postoperative incision infection in colorectal cancer surgery patients, a study was conducted in which 240 patients were included. Study participants were randomly divided into two groups. According to doctor's advice, patients in the control group received routine treatment and care, while patients in the experimental group received traditional Chinese medicine fumigation with Jefuyin decoction. Incision infection rates in patients in the two groups were compared. In addition, enrolled patients were divided into infection group and non-infection group according to the occurrence of postoperative incision infection. Risk factors attributed to infection included diabetes, a history of abdominal surgery, preoperative radiotherapy and chemotherapy
{"title":"RISK FACTORS FOR POSTOPERATIVE INCISIONAL INFECTION AND ANTI-INFECTIVE EFFECTS OF JEFUYIN DECOCTION IN PATIENTS WITH COLORECTAL CANCER","authors":"JINZHI TAN","doi":"10.31925/farmacia.2023.5.22","DOIUrl":"https://doi.org/10.31925/farmacia.2023.5.22","url":null,"abstract":"To investigate the risk factors for postoperative incision infection in colorectal cancer surgery patients, a study was conducted in which 240 patients were included. Study participants were randomly divided into two groups. According to doctor's advice, patients in the control group received routine treatment and care, while patients in the experimental group received traditional Chinese medicine fumigation with Jefuyin decoction. Incision infection rates in patients in the two groups were compared. In addition, enrolled patients were divided into infection group and non-infection group according to the occurrence of postoperative incision infection. Risk factors attributed to infection included diabetes, a history of abdominal surgery, preoperative radiotherapy and chemotherapy","PeriodicalId":12344,"journal":{"name":"FARMACIA","volume":"12 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139313403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-26DOI: 10.31925/farmacia.2023.5.6
Plamen KRASTEV
Monoammonium glycyrrhizinate (MAG), as a derivative of glycyrrhizic acid, has anti-inflammatory, anti-allergic, anti-tumour, antimicrobial, antioxidant, anti-diabetic, anti-ulcer and hepatoprotective effects. In this study, we aimed to investigate the anti-inflammatory activity of MAG on hapten-induced experimental colitis. MAG in doses of 30 and 50 mg/kg bw was injected intraperitoneally for 6 days, starting one day before inducing colitis with 2,4-dinitrobenzene sulfonic acid. On day 6, colon segments were scored for macroscopic and histological damage. Blood samples were taken in order to measure levels of cytokines by ELISA methods. Our data showed that MAG at a dose of 50 mg/kg bw improved clinical symptoms and macroscopic and histological damage to the colon in all the rats with colitis. MAG significantly affected the serum concentrations of the inflammatory cytokines TNF-α, IL-1 and IL-6 and the level of the anti-inflammatory cytokine IL-10 on day 6 after induction of colitis. These findings indicate that MAG significantly inhibits colonic inflammatory damage in a rat model of inflammatory bowel disease.
{"title":"ANTI-INFLAMMATORY EFFECT OF MONOAMMONIUM GLYCYRRHIZINATE ON EXPERIMENTAL COLITIS","authors":"Plamen KRASTEV","doi":"10.31925/farmacia.2023.5.6","DOIUrl":"https://doi.org/10.31925/farmacia.2023.5.6","url":null,"abstract":"Monoammonium glycyrrhizinate (MAG), as a derivative of glycyrrhizic acid, has anti-inflammatory, anti-allergic, anti-tumour, antimicrobial, antioxidant, anti-diabetic, anti-ulcer and hepatoprotective effects. In this study, we aimed to investigate the anti-inflammatory activity of MAG on hapten-induced experimental colitis. MAG in doses of 30 and 50 mg/kg bw was injected intraperitoneally for 6 days, starting one day before inducing colitis with 2,4-dinitrobenzene sulfonic acid. On day 6, colon segments were scored for macroscopic and histological damage. Blood samples were taken in order to measure levels of cytokines by ELISA methods. Our data showed that MAG at a dose of 50 mg/kg bw improved clinical symptoms and macroscopic and histological damage to the colon in all the rats with colitis. MAG significantly affected the serum concentrations of the inflammatory cytokines TNF-α, IL-1 and IL-6 and the level of the anti-inflammatory cytokine IL-10 on day 6 after induction of colitis. These findings indicate that MAG significantly inhibits colonic inflammatory damage in a rat model of inflammatory bowel disease.","PeriodicalId":12344,"journal":{"name":"FARMACIA","volume":"103 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139313490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-26DOI: 10.31925/farmacia.2023.5.9
Iosif ILIA
{"title":"IN VITRO ASSESSMENT OF TWO TYPES OF HYALURONIC ACID’S ANTITUMOR POTENTIAL IN OSTEOSARCOMA CELLS","authors":"Iosif ILIA","doi":"10.31925/farmacia.2023.5.9","DOIUrl":"https://doi.org/10.31925/farmacia.2023.5.9","url":null,"abstract":"","PeriodicalId":12344,"journal":{"name":"FARMACIA","volume":"23 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139313572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：